Key result
Joint S-ICD and CCM therapy shows no device interference in a chronic HF patient.
Why the study?
Is the joint operation of a subcutaneous cardioverter-defibrillator and a cardiac contractility modulation device safe and feasible in a patient with chronic heart failure?
Is the joint operation of a subcutaneous cardioverter-defibrillator and a cardiac contractility modulation device safe and feasible in a patient with chronic heart failure?
Answers are grounded in this paper and cite their sources.
Concomitant implantation of a subcutaneous cardioverter-defibrillator and a cardiac contractility modulation device was feasible without adverse device-device interaction in a single patient.
A clinical case of patient with implanted system subcutaneous cardioverter-defibrillator and cardiac contractility modulation device is described. No violations were identified in the joint operation of the devices.
No takes yet. Share an insight, caveat, or question.
Amanatova et al. (2024) studied this question. Joint operation of a subcutaneous cardioverter-defibrillator and a cardiac contractility modulation device showed no interference in a patient with chronic heart failure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: